Monoclonal Mouse anti‑Human Complement C9 Antibody (clone X197, Concentrated, IHC, WB) LS‑C202491
Monoclonal Mouse anti‑Human Complement C9 Antibody (clone X197, Concentrated, IHC, WB) LS‑C202491
Antibody:
Complement C9 Mouse anti-Human Monoclonal (Concentrated) (X197) Antibody
Application:
IHC, IHC-P, IHC-Fr, WB, Flo
Format:
Unconjugated, Concentrated
Overview
Antibody:
Complement C9 Mouse anti-Human Monoclonal (Concentrated) (X197) Antibody
Application:
IHC, IHC-P, IHC-Fr, WB, Flo
Format:
Unconjugated, Concentrated
Specifications
Description
Complement C9 antibody LS-C202491 is an unconjugated mouse monoclonal antibody to human Complement C9. Validated for Flow, IHC and WB.
Target
Human Complement C9
Synonyms
C9 | Complement C9 | Complement component 9 | Complement component C9
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Modifications
Concentrated
Applications
- IHC
- IHC - Paraffin
- IHC - Frozen
- Western blot
- Flow Cytometry
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.1% BSA
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, ICC, Immunofluorescence, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, IHC - Frozen, Western blot, Flow Cytometry, Functional Assay
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, IHC - Frozen, Western blot, Flow Cytometry, ELISA, Functional Assay
Species:
Human
Applications:
IHC, Western blot, ELISA
Species:
Human
Applications:
ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/2/2024